FEMTO Engineering was one of the nine partners in this regional consortium who contributed their technological bricks toimprove methods for producing innovative medicines and in order to reduce their cost.
Lancé en 2017, MiMédI launched in 2017, is part of the European strategy for innovation through smart specialization of regions (RIS3). With a total cost of €15 million, it was co-financed for an amount of €11,283,209.47 by the European Regional Economic Development Funds (the ERDF program of the European Union) and of €584,000 by the BPI through the regional innovation support fund.
This project made it possible to highlight a strong panel of regional skills: University of Franche-Comté, Établissement Français du Sang Bourgogne-Franche-Comté, CHU de Besançon, UMR RIGHT, FEMTO-ST, FEMTO Engineering and an entire industrial ecosystem (Ilsa, AUREA Technology, Diaclone, Med'Inn Pharma and Smaltis).
More info on the project: ICHERE
Find all our activities on https://www.femto-engineering.fr/femto-activites/
